Eli Lilly Buys Merida Biosciences for Up to $2.88 Billion to Boost Immunology Business

Eli Lilly is acquiring Merida Biosciences for up to $2.88 billion, strengthening its immunology division. The deal is funded by profits from the company's successful weight-loss drugs.

Comments

Read this story in other languages

de fr it es tr nl

Covered by the press in 2 countries

Among the outlets we follow

Germany2
Austria1

Eli Lilly Buys Merida Biosciences for Up to $2.88 Billion to Boost Immunology Business

Comments

Covered by the press in 2 countries

Similar News from External Sources

DOWNLOAD OUR APP